Involvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins

Journal of Translational Medicine

Volumn 9, Issue , 2011, Pages

  Buonomo, Tonia ^a   Carraresi, Laura ^b   Rossini, Mara ^c   Martinelli, Rosanna ^a,d  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; PROTEIN E6; PROTEIN E7; E6 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOGENE PROTEIN E7, HUMAN PAPILLOMAVIRUS TYPE 16; ONCOPROTEIN; REPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC TRANSCRIPTION; HUMAN PAPILLOMAVIRUS TYPE 16; LUNG CARCINOGENESIS; LUNG SMALL CELL CANCER; MOUSE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIRUS CARCINOGENESIS; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; MICROARRAY ANALYSIS; PATHOLOGY; PHYSIOLOGY; VALIDATION STUDY; VIROLOGY;

ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN PAPILLOMAVIRUS 16; HUMANS; LUNG NEOPLASMS; MICE; MICE, TRANSGENIC; MICROARRAY ANALYSIS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; PAPILLOMAVIRUS INFECTIONS; RECEPTORS, ARYL HYDROCARBON; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA;

EID: 78650780317     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-9-2     Document Type: Article

References (37)

1. Psyrri A, DiMaio D. Human papillomavirus in cervical and head-and neck cancer. Nat Clin Pract Oncol 2008, 5:24-31. 10.1038/ncponc0984, 18097454.
2. Crum CP, McLachlin CM, Tate JE, Mutter GL. Pathobiology of vulvar squamous neoplasia. Curr Opin Obstet Gynecol 1997, (9):63-69.
3. Kayes O, Ahmed HU, Arya M, Minhas S. Molecular and genetic pathways in penile cancer. Lancet Oncol 2007, 8:420-429. 10.1016/S1470-2045(07)70137-7, 17466899.
4. Syrjänen KJ. HPV infections and oesophageal cancer. J Clin Pathol 2002, 55:721-728. 1769774, 12354793, 10.1136/jcp.55.10.721.
5. Lyronis ID, Baritaki S, Bizakis I, Tsardi M, Spandidos DA. Evaluation of the prevalence of human papillomavirus and Epstein-Barr virus in esophageal squamous cell carcinomas. Int J Biol Markers 2005, 20:5-10.
6. Ostwald C, Rutsatz K, Schweder J, Schmidt W, Gundlach K, Barten M. Human papillomavirus 6/11 16 and 18 in oral carcinomas and benign oral lesions. Med Microbiol Immunol 2003, 192:145-148. 10.1007/s00430-002-0161-y, 12920590.
7. Syrjanen KJ. Condylomatous changes in neoplastic bronchial epithelium. Report of a case. Respiration 1979, 38:299-304. 10.1159/000194095, 538337.
8. Giuliani L, Favalli C, Syrjanen K, Ciotti M. Human papillomavirus infections in lung cancer. Detection of E6 and E7 transcripts and review of the literature. Anticancer Res 2007, 27:2697-704.
9. Cheng YW, Chiou HL, Sheu GT, Hsieh LL, Chen JT, Chen CY, et al. The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res 2001, 61:2799-2803.
10. Chiou HL, Wu MF, Liaw YC, Cheng YW, Wong RH, Chen CY, Lee H. The presence of human papillomavirus type 16/18 DNA in blood circulation may act as a risk marker of lung cancer in Taiwan. Cancer 2003, 97:1558-1563. 10.1002/cncr.11191, 12627521.
11. Klein F, Amin Kotb WF, Petersen I. Incidence of human papilloma virus in lung cancer. Lung Cancer 2009, 65:13-18. 10.1016/j.lungcan.2008.10.003, 19019488.
12. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol 2002, 64:681-708. 10.1146/annurev.physiol.64.081501.155828, 11826285.
13. Syrianen KJ. HPV infections and lung cancer. J Clin Pathol 2002, 55:885-891. 10.1136/jcp.55.12.885, 1769837, 12461047.
14. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat Rev Cancer 2002, 2:342-350. 10.1038/nrc798, 12044010.
15. Carraresi L, Tripodi SA, Mulder LC, Bertini S, Nuti S, Schuerfeld K, et al. Thymic hyperplasia and lung carcinomas in a line of mice transgenic for keratin 5-driven HPV16 E6/E7 oncogenes. Oncogene 2001, 20:8148-8153. 10.1038/sj.onc.1205007, 11781829.
16. Carraresi L, Martinelli R, Vannoni A, Riccio M, Dembic M, Tripodi S, et al. Establishment and characterization of murine small cell lung carcinoma cell lines derived from HPV-16 E6/E7 transgenic mice. Cancer Lett 2006, 231:65-73. 10.1016/j.canlet.2005.01.027, 16356832.
17. Bélanger MM, Roussel E, Couet J. Caveolin-1 is down-regulated in human lung carcinoma and acts as a candidate tumor suppressor gene. Chest 2004, 125(5 Suppl):106S.
18. Daniel VC, Marchionni L, Hierman JS, Rhodes JT, Devereux WL, Rudin CM, et al. A primary xenograft model of small-cell lung cancer reveals irreversible changes in gene expression imposed by culture in vitro. Cancer Res 2009, 69(8):3364-3373. 10.1158/0008-5472.CAN-08-4210, 2821899, 19351829.
19. Schaffer BE, Park KS, Yiu G, Conklin JF, Lin C, Burkhart DL, et al. Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma. Cancer Res 2010, 70(10):3877-3883. 10.1158/0008-5472.CAN-09-4228, 20406986.
20. Rohrbeck A, Neukirchen J, Rosskopf M, Pardillos GG, Geddert H, Schwalen A, et al. Gene expression profiling for molecular distinction and characterization of laser captured primary lung cancers. J Transl Med 2008, 7:6-69.
21. Klaes R, Friedrich T, Spitkovsky D, Ridder R, Rudy W, Petry U, et al. Overexpression of p16 (INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 2001, 92:276-284. 10.1002/ijc.1174, 11291057.
22. Jones EE, Wells SI. Cervical cancer and human papillomaviruses:inactivation of retinoblastoma and other tumor suppressor pathways. Curr Mol Med 2006, 6:795-808.
23. Mantovani F, Banks L. The human papillomavirus E6 protein and its contribution to malignant progression. Oncogene 2001, 20:7874-7887. 10.1038/sj.onc.1204869, 11753670.
24. Munger K, Basile JR, Duensing S. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 2001, 20:7888-7898. 10.1038/sj.onc.1204860, 11753671.
25. Jones DL, Alani RM, Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p 21Cip1-mediated inhibition of cdk2. Genes Dev 1997, 11:2101-2111. 10.1101/gad.11.16.2101, 316455, 9284049.
26. Steenbergen RD, de Wilde J, Wilting SM, Brink AA, Snijders PJ, Meijer CJ. HPV-mediated transformation of the anogenital tract. J Clin Virol 2005, 32:S25-33. 10.1016/j.jcv.2004.11.019, 15753009.
27. Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM. Could human papillomaviruses be spread through blood?. J Clin Microbiol 2005, 43:5428-5434. 10.1128/JCM.43.11.5428-5434.2005, 1287818, 16272465.
28. Anaya-Saavedra G, Ramírez-Amador V, Irigoyen-Camacho ME, Méndez- Martínez R, García-Carrancá A. High association of human papillomavirus infection with oral cancer: a case-control study. Arch Med Res 2008, 39:189-197. 10.1016/j.arcmed.2007.08.003, 18164962.
29. Wang X, Tian X, Liu F, Zhao Y, Sun M, Chen D, et al. Detection of HPV DNA in esophageal cancer specimens from different regions and ethnic groups: a descriptive study. BMC Cancer 2010, 16:10-19.
30. Deschoolmeester V, Van Marck V, Baay M, Weyn C, Vermeulen P, Van Marck E, et al. Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer. BMC Cancer 2010, 26;10:117.
31. Marur S, D'Souza G, Westra WH, Forastiere AA. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010, 11:781-789. 10.1016/S1470-2045(10)70017-6, 20451455.
32. Rezazadeh A, Laber DA, Ghim SJ, Jenson AB, Kloecker G. The role of human papilloma virus in lung cancer: a review of the evidence. Am J Med Sci 2009, 338:64-67. 10.1097/MAJ.0b013e3181a393ba, 19593105.
33. Fan Y, Boivin GP, Knudsen ES, Nebert DW, Xia Y, Puga A. The aryl hydrocarbon receptor functions as a tumor suppressor of liver carcinogenesis. Cancer Res 2010, 70:212-220. 10.1158/0008-5472.CAN-09-3090, 2939500, 19996281.
34. Puga A, Xia Y, Elferink C. Role of the aryl hydrocarbon receptor in cell cycle regulation. Chem Biol Interact 2002, 141:117-130. 10.1016/S0009-2797(02)00069-8, 12213388.
35. Chang X, Fan Y, Karyala S, Schwemberger S, Tomlinson CR, Sartor MA, et al. Ligand-independent regulation of transforming growth factor β1 expression and cell cycle progression by the aryl hydrocarbon receptor. Mol Cell Biol 2007, 27:6127-6139. 10.1128/MCB.00323-07, 1952156, 17606626.
36. Elizondo G, Fernandez-Salguero P, Sheikh MS, Kim GY, Fornace AJ, Lee KS, et al. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol Pharmacol 2000, 57:1056-1063.
37. Marlowe JL, Fan Y, Chang X, Peng L, Knudsen ES, Xia Y, et al. The aryl hydrocarbon receptor binds to E2F1 and inhibits E2F1-induced apoptosis. Mol Biol Cell 2008, 19:3263-3271. 10.1091/mbc.E08-04-0359, 2488290, 18524851.